Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Anika Therapeutics (ANIK) Shares Issued: 2010-2025

Historic Shares Issued for Anika Therapeutics (ANIK) over the last 10 years, with Jun 2025 value amounting to $261,000.

  • Anika Therapeutics' Shares Issued fell 32.73% to $261,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $969,000, marking a year-over-year decrease of 19.85%. This contributed to the annual value of $708,000 for FY2024, which is 12.05% down from last year.
  • As of Q2 2025, Anika Therapeutics' Shares Issued stood at $261,000, which was down 12.12% from $297,000 recorded in Q4 2024.
  • Over the past 5 years, Anika Therapeutics' Shares Issued peaked at $650,000 during Q4 2022, and registered a low of $7,000 during Q1 2023.
  • For the 3-year period, Anika Therapeutics' Shares Issued averaged around $253,429, with its median value being $297,000 (2024).
  • Per our database at Business Quant, Anika Therapeutics' Shares Issued tumbled by 92.17% in 2021 and then surged by 470.18% in 2022.
  • Quarterly analysis of 5 years shows Anika Therapeutics' Shares Issued stood at $114,000 in 2021, then skyrocketed by 470.18% to $650,000 in 2022, then plummeted by 46.31% to $349,000 in 2023, then decreased by 14.90% to $297,000 in 2024, then slumped by 32.73% to $261,000 in 2025.
  • Its last three reported values are $261,000 in Q2 2025, $297,000 for Q4 2024, and $388,000 during Q2 2024.